Company profile for Onconova Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova has three product candidates in clinical trials and seve...
Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova has three product candidates in clinical trials and several active pre-clinical programs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
CORPORATE OFFICE 375 Pheasant Run Newtown, PA 18940
Telephone
Telephone
+1-267-759-3680
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/04/02/2855819/0/en/Traws-Pharma-Announces-New-Employee-Inducement-Grants.html

GLOBENEWSWIRE
02 Apr 2024

https://www.globenewswire.com/news-release/2024/04/02/2855799/0/en/Onconova-Therapeutics-Inc-and-Trawsfynydd-Therapeutics-Inc-Announce-Business-Combination-to-Form-Traws-Pharma-Inc-a-Best-in-Class-Virology-and-Oncology-Company.html

GLOBENEWSWIRE
02 Apr 2024

https://www.globenewswire.com/news-release/2024/03/08/2843074/0/en/Onconova-Therapeutics-Rigosertib-Poster-Selected-for-AACR-2024.html

GLOBENEWSWIRE
08 Mar 2024

https://www.globenewswire.com//news-release/2023/12/12/2794697/0/en/Onconova-Therapeutics-Narazaciclib-ASH-Poster-Highlights-Activity-in-Treatment-Resistant-Mantle-Cell-Lymphoma.html

GLOBENEWSWIRE
12 Dec 2023

https://www.globenewswire.com//news-release/2023/12/08/2793371/0/en/Onconova-Therapeutics-Preclinical-Narazaciclib-Data-at-SABCS-Highlights-Differentiated-Anti-Tumor-Activity-v-Other-CDK4-6i-s.html

GLOBENEWSWIRE
08 Dec 2023

https://www.globenewswire.com//news-release/2023/11/28/2786864/0/en/Onconova-Therapeutics-to-Present-at-NobleCon19-Noble-Capital-Markets-Nineteenth-Annual-Emerging-Growth-Equity-Conference.html

GLOBENEWSWIRE
28 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty